Clinical Trials Browser

Phase 2 × Fallopian Tube Neoplasms × Sunitinib × Clear all

NCT00768144 2018-08-24

Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma

Phase 2 Completed

36 enrolled 10 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00543049 2014-03-07

Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor

Phase 2 Completed

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms